ANGLE INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TR

The study investigated 123 metastatic ovarian cancer patients over two and a half years using the Parsortix system to assess 474 longitudinal patient samples Downstream qPCR molecular analysis of the Parsortix harvest for ESR1 and ERCC1 genes may be an early predictor of progression free survival and cancer pro...

Related Keywords

United States ,France ,Germany ,Vienna ,Wien ,Austria ,Belgium ,American ,Karen Miller ,University Of Vienna ,Framework Programme Grant ,International Journal Of Cancer ,American Cancer Society ,Framework Programme ,Medical University ,International Journal ,Scientific Officer ,Global Cancer Facts ,